Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC contacting LC
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)Bay
|
BCM
|
Organ Weight / Spleen weight
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Organ Weight / Spleen weight
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0396
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Organ Weight / Spleen weight
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.719
|
Successful |
Ap4e1em1(IMPC)Bay
|
BCM
|
Organ Weight / Spleen weight
|
HET
|
5f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.996
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC contacting LC
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD8 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 T cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.490
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes - % of myeloid cells
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of B220+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
2.95×10-06
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00263
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0800
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
3f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0981
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.192
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.280
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.415
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.470
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.575
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.584
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.724
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.778
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.851
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.867
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Haematology test / Haemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
1.01×10-05
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Haematology test / Haematocrit
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00596
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Haematology test / White blood cell-count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.383
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Haematology test / Red Blood Cell-count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000378
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / Eosinophils
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / Eosinophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / Eosinophils
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / Eosinophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / Eosinophils
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / Eosinophils
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.225
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Haematology test / Platelets-count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00691
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Haematology test / Mean-cell-volume
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Haematology test / Mean-corpuscular-haemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
1.01×10-10
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total myeloid cells - % of CD45+
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B cells - % of CD45+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Eosinophil differential count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Eosinophil differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00880
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Eosinophil differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.116
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Eosinophil differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.171
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Eosinophil differential count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.183
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Eosinophil differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.308
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Eosinophil differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.616
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Eosinophil differential count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.770
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean platelet volume
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Mean platelet volume
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0558
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / Mean platelet volume
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0725
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Mean platelet volume
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0852
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean platelet volume
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0853
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Mean platelet volume
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.127
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Mean platelet volume
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.564
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean platelet volume
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.578
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Mean platelet volume
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.883
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.239
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd T cells - % of gd T cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - % of DC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - % of gd T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.662
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD25+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.439
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Cytotoxic T cell function / % lysis
|
HOM
|
12f:12m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Organ Weight / Spleen weight
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Organ Weight / Spleen weight
|
HOM
|
1f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0272
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Organ Weight / Spleen weight
|
HOM
|
f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.716
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ mature NK cells - % of mature NK cells
|
HOM
|
f:2m
|
Supplied as data
|
1.00
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Vg5+ dendritic epidermal T cell (DETC) count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - % of B2 cells
|
HOM
|
1f:2m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / CD8+CD44+CD62L- percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.445
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Gross Pathology and Tissue Collection / Spleen
|
HOM
|
f:m
|
Supplied as data
|
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Gross Pathology and Tissue Collection / Spleen
|
HOM
|
f:m
|
Supplied as data
|
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / B1B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / B1B Cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / B1B Cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / B1B Cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / B1B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / B1B Cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.478
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.414
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes - % of myeloid cells
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Hematocrit
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Hematocrit
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Hematocrit
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Hematocrit
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000195
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / Hematocrit
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00166
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Hematocrit
|
HOM
|
3f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00439
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Hematocrit
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0205
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Hematocrit
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0428
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Hematocrit
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.195
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Hematocrit
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
5.17×10-05
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Hematocrit
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.244
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Hematocrit
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.496
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / Hematocrit
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.617
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Hematocrit
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.719
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Hematocrit
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.808
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Hematocrit
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, including Weight
|
0.813
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Hematocrit
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.820
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.617
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Antigen Specific Immunoglobulin Assay / TetC specific total IgG
|
HOM
|
f:4m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DN NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN NKT cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.312
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of B220+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Myeloid cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.595
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.359
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / RP Macrophage (F4/80+)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Large Unstained Cell (LUC) count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.209
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Large Unstained Cell (LUC) count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.730
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Large Unstained Cell (LUC) count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.786
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Gross Pathology and Tissue Collection / Lymph node
|
HOM
|
f:m
|
Supplied as data
|
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of DC
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Lymphocyte cell count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Lymphocyte cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0523
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Lymphocyte cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.168
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Lymphocyte cell count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.280
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Lymphocyte cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.557
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Lymphocyte cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.698
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Lymphocyte cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.727
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Lymphocyte cell count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.763
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of NK cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / T cell CD8+ percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD4+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Platelet count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Platelet count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Platelet count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Platelet count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0706
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Platelet count
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0706
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / Platelet count
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.107
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Platelet count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.220
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Platelet count
|
HOM
|
3f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.337
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Platelet count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.341
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Platelet count
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.390
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / Platelet count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.466
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Platelet count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.602
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Platelet count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.661
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Platelet count
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.843
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Platelet count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.847
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Platelet count
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, including Weight
|
0.847
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Platelet count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.986
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / Monocytes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / Monocytes
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / Monocytes
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / Monocytes
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / Monocytes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / Monocytes
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0851
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC not contacting LC
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of B2 cells
|
HOM
|
1f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ CD5+ T cells - % of CD5+ T cells
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC not contacting LC
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN T cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DN T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - % of myeloid cells
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / T Cells (panel B)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.302
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd T cells - % of gd T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / Follicular B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / Follicular B Cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / Follicular B Cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of LC
|
HOM
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Granulocyte Gr1+ percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD25- NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - % of myeloid cells
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - % of B cells
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Eosinophil cell count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Eosinophil cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0586
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Eosinophil cell count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.139
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Eosinophil cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.140
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Eosinophil cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.302
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Eosinophil cell count
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.410
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Eosinophil cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.434
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Eosinophil cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.585
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - % of NK cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / cDCs
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / cDCs
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / cDCs
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / cDCs
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / cDCs
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / cDCs
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.511
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Hemoglobin
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Hemoglobin
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Hemoglobin
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Hemoglobin
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
8.51×10-06
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Hemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00111
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Hemoglobin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00222
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Hemoglobin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00270
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / Hemoglobin
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0162
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Hemoglobin
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0780
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Hemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0807
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Hemoglobin
|
HOM
|
3f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.163
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Hemoglobin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.301
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / Hemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.469
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Hemoglobin
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.497
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Hemoglobin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.685
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Hemoglobin
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.869
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Hemoglobin
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.969
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / NK Subsets (Q2)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.623
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of gd T cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / NK cells (panel A)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.838
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - % of cDC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / B2B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / B2B Cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / B2B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / B2B Cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / B2B Cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / B2B Cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.274
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of B220+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / T cell CD3+ percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ NKT cells - % of NKT cells
|
HOM
|
f:2m
|
Supplied as data
|
1.00
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Neutrophil differential count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Neutrophil differential count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0837
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Neutrophil differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.106
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Neutrophil differential count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.201
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Neutrophil differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.281
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Neutrophil differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.433
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Neutrophil differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.739
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Neutrophil differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.815
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - % of myeloid cells
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / NKT Subsets (Q1)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.162
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Granulocytes - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD25+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.339
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NK cells - % of CD45+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Lymphocyte differential count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Lymphocyte differential count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0428
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Lymphocyte differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0733
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Lymphocyte differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.129
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Lymphocyte differential count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.224
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Lymphocyte differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.229
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Lymphocyte differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.309
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Lymphocyte differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.835
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.279
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.642
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - % of myeloid cells
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Mature NK cells - % of NK cellls
|
HOM
|
f:2m
|
Supplied as data
|
1.00
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / Neutrophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / Neutrophils
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / Neutrophils
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / Neutrophils
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / Neutrophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / Neutrophils
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.149
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of NK cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Monocyte differential count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Monocyte differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0278
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Monocyte differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0290
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Monocyte differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.145
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Monocyte differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.220
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Monocyte differential count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.235
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Monocyte differential count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.256
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Monocyte differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.939
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.857
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD25+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - % of total T cells
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Plasma cells - % of CD45+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - % of Treg
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - % of total T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Antigen Specific Immunoglobulin Assay / TetC specific IgG1
|
HOM
|
f:4m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of LC
|
HOM
|
1f:2m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - % of NK cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of Treg
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.254
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - % of total T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / NK Subsets (Q1)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.762
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
DSS Histology / Pre-Day 10 Death
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell volume
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Mean cell volume
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean cell volume
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Mean cell volume
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Mean cell volume
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00570
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Mean cell volume
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0333
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Mean cell volume
|
HOM
|
3f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0469
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Mean cell volume
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0979
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Mean cell volume
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.285
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Mean cell volume
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.356
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean cell volume
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.420
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / Mean cell volume
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.543
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Mean cell volume
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.555
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Mean cell volume
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.579
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Mean cell volume
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.707
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Mean cell volume
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.743
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Mean cell volume
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.943
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total myeloid cells - % of CD45+
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of B220+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - % of total T cells
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Basophil cell count
|
HOM
|
8f:8m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Basophil cell count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Basophil cell count
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Basophil cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0777
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Basophil cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.115
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Basophil cell count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.249
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Basophil cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.750
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Basophil cell count
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.776
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - % of B cells
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - % of cDC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Red blood cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Red blood cell count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Red blood cell count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Red blood cell count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
7.03×10-05
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Red blood cell count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00551
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Red blood cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00764
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / Red blood cell count
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00890
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Red blood cell count
|
HOM
|
3f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0402
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Red blood cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0432
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Red blood cell count
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0449
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Red blood cell count
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.279
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.498
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Red blood cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.639
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Red blood cell count
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.645
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Red blood cell count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.683
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Red blood cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.892
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Red blood cell count
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.975
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / B cell CD19+ percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.296
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
7f:8m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
8f:8m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
8f:8m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
8f:8m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.290
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Mature B cell IgD+ percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / MZB
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of cDC
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / T cell CD4+ percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - % of B cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0428
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Neutrophil cell count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Neutrophil cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0535
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Neutrophil cell count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0581
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Neutrophil cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.695
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Neutrophil cell count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.791
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Neutrophil cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.861
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Neutrophil cell count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.926
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Neutrophil cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.950
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - % of myeloid cells
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / T Subset
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / T Subset
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / T Subset
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / T Subset
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / T Subset
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.313
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ immature NK cells - % of immature NK cells
|
HOM
|
f:2m
|
Supplied as data
|
1.00
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of Treg
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - % of B220+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Monocytes - % of myeloid cells
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Total B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Organ Weight / Thymus weight
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Organ Weight / Thymus weight
|
HOM
|
f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0375
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Organ Weight / Thymus weight
|
HOM
|
f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.213
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
DSS Histology / Average histology score
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - % of DC
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / Transitional B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / Transitional B Cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / Transitional B Cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - % of Treg
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Organ Weight / Spleen weight
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.298
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA classification
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Monocyte cell count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Monocyte cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0598
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Monocyte cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0603
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Monocyte cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.268
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Monocyte cell count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.465
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Monocyte cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.468
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Monocyte cell count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.562
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Monocyte cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.885
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Immature NK cells - % of NK cells
|
HOM
|
f:2m
|
Supplied as data
|
1.00
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / CD4+CD44+CD62L- percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NKT cells - % of CD45+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NK cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.565
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD25- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
1.64×10-06
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0770
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0895
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.176
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
3f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.182
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.456
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.494
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.562
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.637
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.659
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.750
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.847
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.868
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.948
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DP T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DP T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DP T cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DP T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DP T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Large Unstained Cell (LUC) differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.315
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Large Unstained Cell (LUC) differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.607
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Large Unstained Cell (LUC) differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.997
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of LC
|
HOM
|
1f:2m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.658
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - % of DC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of B220+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD4 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 T cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.253
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Basophil differential count
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Basophil differential count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Basophil differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0758
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Basophil differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.195
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Basophil differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.229
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / Basophil differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.282
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Basophil differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.336
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Basophil differential count
|
HOM
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.800
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - % of myeloid cells
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.686
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Monocytes - % of myeloid cells
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / pDCs
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / pDCs
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / pDCs
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / pDCs
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Red blood cell distribution width
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / Red blood cell distribution width
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
7.10×10-05
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / Red blood cell distribution width
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00449
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / Red blood cell distribution width
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0772
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / Red blood cell distribution width
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0813
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / Red blood cell distribution width
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.240
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / Red blood cell distribution width
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.377
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell distribution width
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.608
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / Red blood cell distribution width
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.720
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Langerhans cell (LC) count
|
HOM
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.871
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on LC
|
HOM
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Clinical Chemistry / Glycosilated hemoglobin A1c (HbA1c)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.212
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of cDC
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of B220+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Treg cell CD25+ percentage
|
HOM
|
9f:9m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.983
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - % of B cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / T cells (panel A)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / T cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / T cells (panel A)
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / T cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / T cells (panel A)
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.110
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total T cells - % of CD45+
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.216
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Immunophenotyping / B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / B Cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / B Cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / B Cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / B Cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.648
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - % of CD4+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.685
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / White blood cell count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / White blood cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / White blood cell count
|
HET
|
f:1m
|
|
|
NotProcessed |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / White blood cell count
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0120
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
TCP
|
Hematology / White blood cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.221
|
Successful |
Ap4e1em2(IMPC)Mbp
|
UC Davis
|
Hematology / White blood cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.237
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / White blood cell count
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.311
|
Successful |
Ap4e1em1(IMPC)J
|
JAX
|
Hematology / White blood cell count
|
HET
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.438
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
UC Davis
|
Hematology / White blood cell count
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.453
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Hematology / White blood cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.462
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
BCM
|
Hematology / White blood cell count
|
HOM
|
3f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.475
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
JAX
|
Hematology / White blood cell count
|
HOM
|
4f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.510
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
MRC Harwell
|
Hematology / White blood cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.641
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
HMGU
|
Hematology / White blood cell count
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.691
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
RBRC
|
Hematology / White blood cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.772
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
CCP-IMG
|
Hematology / White blood cell count
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.774
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
ICS
|
Hematology / White blood cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.781
|
Successful |
Ap4e1tm1b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HOM
|
2f:3m
|
Supplied as data
|
1.00
|
Successful |